These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease. Nash JE, Ravenscroft P, McGuire S, Crossman AR, Menniti FS, Brotchie JM. Exp Neurol; 2004 Aug 01; 188(2):471-9. PubMed ID: 15246846 [Abstract] [Full Text] [Related]
12. Norastemizole Sepracor. Bachmann KA. Curr Opin Investig Drugs; 2000 Oct 01; 1(2):219-26. PubMed ID: 11249577 [Abstract] [Full Text] [Related]